Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Veterans Crisis Line Badge
Go to the ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

341 records found for:
Title = Pneumonia
Year =

  1. Jones BE, Ying J, Stevens V, Haroldsen C, He T, Nevers M, Christensen MA, Nelson RE, Stoddard GJ, Sauer BC, Yarbrough PM, Jones MM, Goetz MB, Greene T, Samore MH. Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia. JAMA internal medicine. 2020 Feb 17.
  2. Bostwick AD, Jones BE, Paine R, Goetz MB, Samore M, Jones M. Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics. An Evaluation of 113 Veterans Affairs Medical Centers. Annals of the American Thoracic Society. 2019 Nov 1; 16(11):1392-1398.
  3. Surendran Nair M, Eucker T, Martinson B, Neubauer A, Victoria J, Nicholson B, Pieters M. Influence of pig gut microbiota on Mycoplasma hyopneumoniae susceptibility. Veterinary research. 2019 Oct 28; 50(1):86.
  4. Wenger DS, Triplette M, Crothers K, Cheng GS, Hill JA, Milano F, Shahrir S, Schoch G, Vande Vusse LK. Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of The American Society For Blood and Marrow Transplantation. 2020 Feb 1; 26(2):413-420.
  5. Baghdadi J, Harris AD. Working Toward Better Metrics for Nonventilator Hospital-Acquired Pneumonia. JAMA Network Open. 2019 Oct 2; 2(10):e1913662.
  6. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine. 2019 Oct 1; 200(7):e45-e67.
  7. Lin JL, Van Haren K, Rigdon J, Saynina O, Song H, Buu MC, Thakur Y, Srinivas N, Asch SM, Sanders LM. Pneumonia Prevention Strategies for Children With Neurologic Impairment. Pediatrics. 2019 Oct 1; 144(4).
  8. Gregory MH, Ciorba MA, Wiitala WL, Stidham RW, Higgins P, Morley SC, Hou JK, Feagins LA, Govani SM, Cohen-Mekelburg SA, Waljee AK. The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2019 Aug 27.
  9. Cusumano JA, Caffrey AR, Daffinee KE, Luther MK, Lopes V, LaPlante KL. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae. Diagnostic Microbiology and Infectious Disease. 2019 Dec 1; 95(4):114877.
  10. Munro SM, Baker D. Integrating Oral Health Care into Patient Management to Prevent Hospital-Acquired Pneumonia: A Team Approach. Michigan Dental Association. 2019 Jul 1; 7(1):48-57.
  11. Zifodya JS, Crothers K. Treating bacterial pneumonia in people living with HIV. Expert review of respiratory medicine. 2019 Aug 1; 13(8):771-786.
  12. Bosco E, Zullo AR, McConeghy KW, Moyo P, van Aalst R, Chit A, Mor V, Gravenstein S. Long-term Care Facility Variation in the Incidence of Pneumonia and Influenza. Open forum infectious diseases. 2019 Jun 1; 6(6):ofz230.
  13. Wang RJ, Moore J, Moisi D, Chang EG, Byanyima P, Kaswabuli S, Musisi E, Sanyu I, Sessolo A, Lalitha R, Worodria W, Davis JL, Crothers K, Lin J, Lederman MM, Hunt PW, Huang L. HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia. PLoS ONE. 2019 May 15; 14(5):e0216680.
  14. Edelman EJ, Gordon KS, Crothers K, Akgün K, Bryant KJ, Becker WC, Gaither JR, Gibert CL, Gordon AJ, Marshall BDL, Rodriguez-Barradas MC, Samet JH, Justice AC, Tate JP, Fiellin DA. Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIV. JAMA internal medicine. 2019 Mar 1; 179(3):297-304.
  15. Jones BE, Collingridge DS, Vines CG, Post H, Holmen J, Allen TL, Haug P, Weir CR, Dean NC. CDS in a Learning Health Care System: Identifying Physicians' Reasons for Rejection of Best-Practice Recommendations in Pneumonia through Computerized Clinical Decision Support. Applied clinical informatics. 2019 Jan 2; 10(1):1-9.
  16. Likosky DS, Harrington SD, Cabrera L, DeLucia A, Chenoweth CE, Krein SL, Thibault D, Zhang M, Matsouaka RA, Strobel RJ, Prager RL. Collaborative Quality Improvement Reduces Postoperative Pneumonia After Isolated Coronary Artery Bypass Grafting Surgery. Circulation. Cardiovascular quality and outcomes. 2018 Nov 1; 11(11):e004756.
  17. Munro S, Haile-Mariam A, Greenwell C, Demirci S, Farooqi O, Vasudeva S. Implementation and Dissemination of a Department of Veterans Affairs Oral Care Initiative to Prevent Hospital-Acquired Pneumonia Among Nonventilated Patients. Nursing Administration Quarterly. 2018 Oct 1; 42(4):363-372.
  18. Munro S, Baker D. Reducing missed oral care opportunities to prevent non-ventilator associated hospital acquired pneumonia at the Department of Veterans Affairs. Applied nursing research : ANR. 2018 Dec 1; 44:48-53.
  19. Jones BE, Haroldsen C, Madaras-Kelly K, Goetz MB, Ying J, Sauer B, Jones MM, Leecaster M, Greene T, Fridkin SK, Neuhauser MM, Samore MH. In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia. Medical care. 2018 Jul 1; 56(7):626-633.
  20. Jones BE, South BR, Shao Y, Lu CC, Leng J, Sauer BC, Gundlapalli AV, Samore MH, Zeng Q. Development and Validation of a Natural Language Processing Tool to Identify Patients Treated for Pneumonia across VA Emergency Departments. Applied clinical informatics. 2018 Feb 21; 9(1):122-128.
  21. Royer S, Prescott HC. Next Steps for Confirming Bronchoalveolar Lavage Amlyase as an Useful Biomarker for Ventilator-Associated Pneumonia. [Editorial]. Critical care medicine. 2018 Jan 1; 46(1):165-166.
  22. Sutton JD, Graber CJ, Goetz MB, Madaras-Kelly K, Jones M, Glassman PA, Spivak E. Visual analytic tools for automated measurement and tracking of durations of therapy for pneumonia, urinary tract infections, and skin and soft tissue infections. [Abstract]. Open forum infectious diseases. 2017 Oct 4; 4(Supplemental 1):S511-S512.
  23. Weir C, Butler J, Sutton JD, Graber CJ, Goetz MB, Madaras-Kelly KJ, Jones M, Samore M, Glassman PA. The experience of stewards in using a visual analytic tool to benchmark and track therapy duration for pneumonia, urinary tract infections, and skin and soft tissue infections. [Abstract]. Open forum infectious diseases. 2017 Oct 4; 4(Supplemental 1):S279-S280.
  24. Angarita SAK, Russell TA, Kaldas FM. Pneumonia after liver transplantation. Current opinion in organ transplantation. 2017 Aug 1; 22(4):328-335.
  25. Batais MA, Khan AR, Bin Abdulhak AA. The Use of Statins and Risk of Community-Acquired Pneumonia. Current Infectious Disease Reports. 2017 Aug 1; 19(8):26.
  26. Viglianti EM, Prescott HC, Liu V, Escobar GJ, Iwashyna TJ. Individual and health system variation in rehospitalizations the year after pneumonia. Medicine. 2017 Aug 1; 96(31):e7695.
  27. Jones BE, Brown KA, Jones MM, Huttner BD, Greene T, Sauer BC, Madaras-Kelly K, Rubin MA, Bidwell Goetz M, Samore MH. Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers. Infection control and hospital epidemiology. 2017 Aug 1; 38(8):937-944.
  28. Hammond DA, Vines CE, McPhee AL, Bhandari NR, Jones KM, Meena N, Painter JT. Effect of Etomidate on Pneumonia Development in Critically Ill, Nontrauma Patients. Journal of Intensive Care Medicine. 2019 Jan 1; 34(1):34-39.
  29. Lee JS, Giesler DL, Fine MJ. Duration of Antibiotic Therapy for Community-Acquired Pneumonia in the Era of Personalized Medicine. JAMA : the journal of the American Medical Association. 2016 Dec 20; 316(23):2544-2545.
  30. Madaras-Kelly KJ, Burk M, Caplinger C, Bohan JG, Neuhauser MM, Goetz MB, Zhang R, Cunningham FE, Pneumonia Duration of Therapy Medication Utilization Evaluation Group. Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: Results of a national medication utilization evaluation. Journal of hospital medicine. 2016 Dec 1; 11(12):832-839.
  31. Rodriguez-Barradas MC, Akgun K, Brown S, Butt A, Fine MJ, Goetz MB, Graber CJ, Huang L, McGinnis K, Rimland D, Justice AC, Crothers K. Community Acquired Pneumonia (CAP) Requiring Hospitalization in HIV Infected (HIV+) and Un-infected (HIV-) Patients: Evaluation of Patients Identified by ICD-9 Codes. Paper presented at: ID Week Annual Conference; 2016 Oct 7; San Diego, CA.
  32. Lee JS, Giesler DL, Fine MJ. Management of Community-Acquired Pneumonia--Reply. [Letter to the Editor]. JAMA : the journal of the American Medical Association. 2016 Jul 12; 316(2):222-3.
  33. Iwashyna T. Increasing ICU Access Can Improve Outcomes for Pneumonia. Paper presented at: Intensive Care and Emergency Medicine International Symposium; 2016 Mar 16; Brussels, Belgium.
  34. Lee JS, Giesler DL, Gellad WF, Fine MJ. Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review. JAMA. 2016 Feb 9; 315(6):593-602.
  35. Madaras-Kelly K, Jones M, Remington R, Caplinger CM, Huttner B, Jones B, Samore M. Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare Administration. The Journal of antimicrobial chemotherapy. 2016 Feb 1; 71(2):539-46.
  36. Walkey AJ, Weinberg J, Wiener RS, Cooke CR, Lindenauer PK. Association of Do-Not-Resuscitate Orders and Hospital Mortality Rate Among Patients With Pneumonia. JAMA internal medicine. 2016 Jan 1; 176(1):97-104.
  37. McDanel JS, Perencevich EN, Diekema DJ, Winokur PL, Johnson JK, Herwaldt LA, Smith TC, Chrischilles EA, Dawson JD, Schweizer ML. Association between microbial characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study. Antimicrobial resistance and infection control. 2015 Dec 14; 4:51.
  38. Borzecki AM, Chen Q, Restuccia J, Mull HJ, Shwartz M, Gupta K, Hanchate A, Strymish J, Rosen A. Do pneumonia readmissions flagged as potentially preventable by the 3M PPR software have more process of care problems? A cross-sectional observational study. BMJ quality & safety. 2015 Dec 1; 24(12):753-63.
  39. Jones BE, Jones MM, Huttner B, Stoddard G, Brown KA, Stevens VW, Greene T, Sauer B, Madaras-Kelly K, Rubin M, Goetz MB, Samore M. Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010. [Abstract]. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Nov 1; 61(9):1403-10.
  40. Barakat LA, Juthani-Mehta M, Allore H, Trentalange M, Tate J, Rimland D, Pisani M, Akgün KM, Goetz MB, Butt AA, Rodriguez-Barradas M, Duggal M, Crothers K, Justice AC, Quagliarello VJ. Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumonia. HIV Medicine. 2015 Aug 1; 16(7):421-30.
  41. Corrales-Medina VF, Taljaard M, Yende S, Kronmal R, Dwivedi G, Newman AB, Elkind MS, Lyles MF, Chirinos JA. Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. American heart journal. 2015 Aug 1; 170(2):306-12.
  42. Mortensen EM, Bollinger M, Fine MJ. Electronic medical record based intervention to reduce length of stay for Veterans hospitalized with pneumonia. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  43. Sjoding MW, Prescott HC, Wunsch H, Iwashyna TJ, Cooke CR. Hospitals with the highest intensive care utilization provide lower quality pneumonia care to the elderly. Critical care medicine. 2015 Jun 1; 43(6):1178-86.
  44. McDanel J, Goto M, Jones M, Franciscus CL, Alexander B, Richardson KK, Perencevich EN. Eleven Year Trends in Antimicrobial Non-Susceptibility among Klebsiella pneumoniae Isolates in the Veterans Health Administration. Poster session presented at: Society for Healthcare Epidemiology of America Annual Scientific Meeting; 2015 May 15; Orlando, FL.
  45. McDanel J, Schweizer ML, Crabb V, Nelson R, Samore M, Khader K, Blevins A, Diekema DJ, Perencevich EN. Incidence of Extended-Spectrum Beta-Lactamase E.coli and Klebsiella pneumoniae Infections in the US: a Systematic Review. Poster session presented at: Society for Healthcare Epidemiology of America Annual Scientific Meeting; 2015 May 15; Orlando, FL.
  46. Corrales-Medina VF, Alvarez KN, Yende S. Hospitalization for pneumonia and risk of cardiovascular disease--reply. JAMA : the journal of the American Medical Association. 2015 May 5; 313(17):1753-4.
  47. Sjoding MW, Iwashyna TJ, Dimick JB, Cooke CR. Gaming hospital-level pneumonia 30-day mortality and readmission measures by legitimate changes to diagnostic coding. Critical care medicine. 2015 May 1; 43(5):989-95.
  48. Madaras-Kelly K, Jones M, Remington R, Caplinger C, Huttner B, Samore M. Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data. BMC infectious diseases. 2015 Apr 25; 15(1):197.
  49. Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CC, Newman A, Loehr L, Folsom AR, Elkind MS, Lyles MF, Kronmal RA, Yende S. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015 Jan 20; 313(3):264-74.
  50. Davydow DS, Hough CL, Zivin K, Langa KM, Katon WJ. Depression and risk of hospitalization for pneumonia in a cohort study of older Americans. Journal of psychosomatic research. 2014 Dec 1; 77(6):528-34.
  51. Lee JS, Fine MJ. The debate on antibiotic therapy for patients hospitalized for pneumonia: where should we go from here? JAMA internal medicine. 2014 Dec 1; 174(12):1901-3.
  52. Lee JS, Nsa W, Hausmann LR, Trivedi AN, Bratzler DW, Auden D, Mor MK, Baus K, Larbi FM, Fine MJ. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA internal medicine. 2014 Nov 1; 174(11):1806-14.
  53. Prescott HC, Sjoding MW, Iwashyna TJ. Diagnoses of early and late readmissions after hospitalization for pneumonia. A systematic review. Annals of the American Thoracic Society. 2014 Sep 1; 11(7):1091-100.
  54. Mattila JT, Fine MJ, Limper AH, Murray PR, Chen BB, Lin PL. Pneumonia. Treatment and diagnosis. Annals of the American Thoracic Society. 2014 Aug 1; 11 Suppl 4:S189-92.
  55. Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, Johnson CS, Alvarez CA, Frei CR, Good C, Restrepo MI, Downs JR, Anzueto A. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA. 2014 Jun 4; 311(21):2199-208.
  56. Tang VL, Halm EA, Fine MJ, Johnson CS, Anzueto A, Mortensen EM. Predictors of rehospitalization after admission for pneumonia in the veterans affairs healthcare system. Journal of hospital medicine. 2014 Jun 1; 9(6):379-83.
  57. Mortensen E, Halm E, Fine MJ, Johnson C, Anuzeto A. Azithromycin is associated with increased cardiac events but lower mortality for older patients hospitalized with pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 24; San Diego, CA.
  58. Hougham GW, Ham SA, Ruhnke GW, Schulwolf E, Auerbach AD, Schnipper JL, Kaboli PJ, Wetterneck TB, Gonzalez D, Arora VM, Meltzer DO. Sequence patterns in the resolution of clinical instabilities in community-acquired pneumonia and association with outcomes. Journal of general internal medicine. 2014 Apr 1; 29(4):563-71.
  59. Flanders SA, Saint S. Measuring pneumonia-related mortality using administrative data: coding and consequences. Annals of internal medicine. 2014 Mar 18; 160(6):430-1.
  60. Wu A, Good C, Downs JR, Fine MJ, Pugh MJ, Anzueto A, Mortensen EM. The association of cardioprotective medications with pneumonia-related outcomes. PLoS ONE. 2014 Jan 28; 9(1):e85797.
  61. Corrales-Medina VF, Taljaard M, Fine MJ, Dwivedi G, Perry JJ, Musher DM, Chirinos JA. Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia. Mayo Clinic proceedings. 2014 Jan 1; 89(1):60-8.
  62. Jones B, Gundlapalli AV, Jones JP, Brown SM, Dean NC. Admission decisions and outcomes of community-acquired pneumonia in the homeless population: a review of 172 patients in an urban setting. American journal of public health. 2013 Dec 1; 103 Suppl 2:S289-93.
  63. Justice AC. Comparing clinical outcomes of HIV-infected to HIV-uninfected older adults hospitalized with community-acquired pneumonia. Poster session presented at: Infectious Diseases Society of America Annual Meeting; 2013 Oct 2; San Francisco, CA.
  64. Huttner B, Jones M, Huttner A, Rubin M, Samore MH. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system. The Journal of antimicrobial chemotherapy. 2013 Oct 1; 68(10):2393-9.
  65. Smith KJ, Wateska A, Nowalk MP, Raymund M, Lee BY, Zimmerman RK, Fine MJ. Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia. Journal of general internal medicine. 2013 Sep 1; 28(9):1157-64.
  66. DeLisle S, Kim B, Deepak J, Siddiqui T, Gundlapalli A, Samore M, D'Avolio L. Using the electronic medical record to identify community-acquired pneumonia: toward a replicable automated strategy. PLoS ONE. 2013 Aug 13; 8(8):e70944.
  67. Davydow DS, Hough CL, Levine DA, Langa KM, Iwashyna TJ. Functional disability, cognitive impairment, and depression after hospitalization for pneumonia. The American journal of medicine. 2013 Jul 1; 126(7):615-24.e5.
  68. Rosen AK, Chen Qi, O'Brien W, Borzecki AM, Frakt AB, Shwartz M, Bauer MS. Assessing the Impact of Serious Mental Illness (SMI) and Substance Use Disorders (SUD) on Risk of Readmission for Patients with Acute Myocardial Infarction, Heart Failure, and Pneumonia in the Veterans Health Administration (VA). Presented at: AcademyHealth Annual Research Meeting; 2013 Jun 25; Baltimore, MD.
  69. Chen Q, Borzecki A, O'Brien W, Mull HJ, Restuccia J, Rosen AK. Validating the 3M™ Potentially Preventable Readmissions Software in a Cohort of Veterans with Pneumonia. Poster session presented at: AcademyHealth Annual Research Meeting; 2013 Jun 24; Baltimore, MD.
  70. Fine MJ, Mortensen EM, Halm E, Anzueto A. Azithromycin is associated with increased cardiac events but lower mortality for patients hospitalized with pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 19; Philadelphia, PA.
  71. Rello J, Molano D, Villabon M, Reina R, Rita-Quispe R, Previgliano I, Afonso E, Restrepo MI, LATINVAP and EUVAP Study Investigators. Differences in hospital- and ventilator-associated pneumonia due to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between Europe and Latin America: a comparison of the EUVAP and LATINVAP study cohorts. Medicina intensiva / Sociedad Española de Medicina Intensiva y Unidades Coronarias. 2013 May 1; 37(4):241-7.
  72. Fine MJ, Hausmann LR, Lee JS, Nsa W, Trivedi A, Bratzler DW, Auden D, Mor M, Baus K, Larbi FM. National trends in processes and outcomes of care for elderly patients hospitalized for pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 27; Denver, CO.
  73. Lee JS, Nsa W, Hausmann LR, Trivedi AN, Bratzler DW, Auden D, Baus K, Larbi FM, Fine MJ. Associations between processes of care and mortality in a national cohort of elderly patients hospitalized for pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 24; Denver, CO.
  74. Gellad WF, Yealy D, Fine M. Computers and the diagnosis of pneumonia. JAMA internal medicine. 2013 Apr 22; 173(8):701-2.
  75. Sibila O, Restrepo MI. Corticosteroids for pneumonia: are we there yet? Respirology (Carlton, Vic.). 2013 Feb 1; 18(2):199-200.
  76. Klompas M, Magill S, Robicsek A, Strymish JM, Kleinman K, Evans RS, Lloyd JF, Khan Y, Yokoe DS, Stevenson K, Samore M, Platt R, CDC Prevention Epicenters Program. Objective surveillance definitions for ventilator-associated pneumonia. Critical care medicine. 2012 Dec 1; 40(12):3154-61.
  77. Mortensen EM, Nakashima B, Cornell J, Copeland LA, Pugh MJ, Anzueto A, Good C, Restrepo MI, Downs JR, Frei CR, Fine MJ. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Dec 1; 55(11):1466-73.
  78. Dick A, Liu H, Zwanziger J, Perencevich E, Furuya EY, Larson E, Pogorzelska-Maziarz M, Stone PW. Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia. BMC health services research. 2012 Nov 26; 12:432.
  79. Chopra V, Rogers MA, Buist M, Govindan S, Lindenauer PK, Saint S, Flanders SA. Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis. The American journal of medicine. 2012 Nov 1; 125(11):1111-23.
  80. Laserna E, Sibila O, Aguilar PR, Mortensen EM, Anzueto A, Blanquer JM, Sanz F, Rello J, Marcos PJ, Velez MI, Aziz N, Restrepo MI. Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia. Chest. 2012 Nov 1; 142(5):1193-9.
  81. Metersky ML, Fine MJ, Mortensen EM. The effect of marital status on the presentation and outcomes of elderly male veterans hospitalized for pneumonia. Chest. 2012 Oct 1; 142(4):982-987.
  82. Wilson BZ, Anzueto A, Restrepo MI, Pugh MJ, Mortensen EM. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia. Critical care medicine. 2012 Aug 1; 40(8):2310-4.
  83. Cecere LM, Williams EC, Sun H, Bryson CL, Clark BJ, Bradley KA, Au DH. Smoking cessation and the risk of hospitalization for pneumonia. Respiratory medicine. 2012 Jul 1; 106(7):1055-62.
  84. Fernandez JF, Levine SM, Restrepo MI. Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia. Chest. 2012 Jul 1; 142(1):231-8.
  85. Fernandez JF, Sibila O, Restrepo MI. Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers. Expert review of clinical pharmacology. 2012 Jul 1; 5(4):445-58.
  86. Janus TJ, Vaughan-Sarrazin MS, Baker LJ, Smith HL. Predictors of pneumonia in trauma patients with pulmonary contusion. Journal of trauma nursing : the official journal of the Society of Trauma Nurses. 2012 Jul 1; 19(3):139-47.
  87. Madaras-Kelly KJ, Remington RE, Sloan KL, Fan VS. Guideline-based antibiotics and mortality in healthcare-associated pneumonia. Journal of general internal medicine. 2012 Jul 1; 27(7):845-52.
  88. Restrepo MI, Anzueto A. Global trends in community-acquired pneumonia. Introduction. Seminars in respiratory and critical care medicine. 2012 Jun 20; 33(3):211-2.
  89. Myint PK, Kwok CS, Majumdar SR, Eurich DT, Clark AB, España PP, Man SY, Huang DT, Yealy DM, Angus DC, Capelastegui A, Rainer TH, Marrie TJ, Fine MJ, Loke YK. The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients. BMJ open. 2012 May 21; 2(3).
  90. Restrepo MI. Process Improvement: Impact on Outcomes of Patients with Pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 21; San Francisco, CA.
  91. Fernandez JF, Restrepo MI, Restrepo RD, Villabon M, Lisboa T, Molano D, Rebolledo C, Barahona D, Previgliano I, Sanchez S, Legarto A, Martin-Loeches I, Rello J. Risk of requiring tracheotomy in mechanical ventilation patients admitted with a diagnosis of pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
  92. Kollef M, Restrepo MI, Jolson H, Clavel M, Michiels B, Kaniga K, Cirillo I, Redman R. A phase 3, double-blind, double-dummy study assessing the safety and efficacy of a short course of doripenem 1 Gram in the treatment of subjects with ventilator-associated pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
  93. Restrepo RD, Restrepo MI, Fernandez JF, Villabon M, Lisboa T, Molano D, Rebolledo C, Barahona D, Previgliano I, Sanchez S, Legarto A, Martin-Loeches I, Rello J. Tracheostomy and risk of ventilator-associated pneumonia at Latin American Intensive Care Units (ICUs). Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
  94. Sibila O, Mortensen EM, Anzueto A, Laserna E, Restrepo MI. Prior cardiovascular disease is associated with increased short and long-term mortality in COPD patients with community-acquired pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
  95. Smith KJ, Zimmerman RK, Wateska A, Nowalk MP, Raymund M, Fine MJ. Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2012 May 10; Orlando, FL.
  96. Restrepo MI. Community-acquired pneumonia. Update. Paper presented at: Pneumology and Thoracic Surgery National Congress (Congreso Nacional de Neumología y Cirugía de Tórax); 2012 Apr 13; Cancun, Mexico.
  97. Sibila O, Mortensen EM, Redrow G, Lugo E, Laserna E, Anzueto A, Restrepo MI. Evaluation of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Hospital practice (1995). 2012 Apr 1; 40(2):158-64.
  98. Rodriguez-Barradas M. Methodology to identify and validate community-acquired pneumonia using administrative data compared to web-based adjudication. Poster session presented at: International Workshop on HIV Observational Databases; 2012 Mar 29; Athens, Greece.
  99. Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL. Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia. Journal of hospital medicine. 2012 Mar 1; 7(3):195-202.
  100. Renaud B, Brun-Buisson C, Santin A, Coma E, Noyez C, Fine MJ, Yealy DM, Labarère J. Outcomes of early, late, and no admission to the intensive care unit for patients hospitalized with community-acquired pneumonia. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2012 Mar 1; 19(3):294-303.
  101. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012 Feb 14; 125(6):773-81.
  102. Klompas M, Kleinman K, Khan Y, Evans RS, Lloyd JF, Stevenson K, Samore M, Platt R, CDC Prevention Epicenters Program. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Feb 1; 54(3):370-7.
  103. Marcos PJ, Restrepo MI, Verea H. Community acquired pneumonia: severity scores as an adjunct to clinical judgement. European Respiratory Journal. 2012 Feb 1; 39(2):509.
  104. Maselli DJ, Fernandez JF, Whong CY, Echevarria K, Nambiar AM, Anzueto A, Restrepo MI. Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia. Infection and drug resistance. 2012 Feb 1; 5:43-51.
  105. Evans CT, Weaver FM, Rogers TJ, Rapacki L, Miskevics S, Hahm B, Smith B, Lavela SL, Goldstein B, Burns SP. Guideline-recommended management of community-acquired pneumonia in veterans with spinal cord injury. Topics in spinal cord injury rehabilitation. 2012 Jan 1; 18(4):300-5.
  106. Restrepo MI. Combination Therapy for Severe Community Acquired Pneumonia. Paper presented at: Pan-American and Iberian Congress of Intensive Care Medicine; 2011 Dec 3; Cartagena, Columbia.
  107. Lee JS, Primack BA, Mor MK, Stone RA, Obrosky DS, Yealy DM, Fine MJ. Processes of care and outcomes for community-acquired pneumonia. The American journal of medicine. 2011 Dec 1; 124(12):1175.e9-17.
  108. Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. European Respiratory Journal. 2011 Oct 1; 38(4):878-87.
  109. Pogorzelska M, Stone PW, Furuya EY, Perencevich EN, Larson EL, Goldmann D, Dick A. Impact of the ventilator bundle on ventilator-associated pneumonia in intensive care unit. International journal for quality in health care : journal of the International Society for Quality in Health Care. 2011 Oct 1; 23(5):538-44.
  110. Hutt E, Ruscin JM, Linnebur SA, Fish DN, Oman KS, Fink RM, Radcliff TA, Van Dorsten B, Liebrecht D, Fish R, McNulty MC. A multifaceted intervention to implement guidelines did not affect hospitalization rates for nursing home-acquired pneumonia. Journal of The American Medical Directors Association. 2011 Sep 1; 12(7):499-507.
  111. Chen D, Restrepo MI, Fine MJ, Pugh MJ, Anzueto A, Metersky ML, Nakashima B, Good C, Mortensen EM. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. American journal of respiratory and critical care medicine. 2011 Aug 1; 184(3):312-6.
  112. Chumbler NR, Williams LS, Wells CK, Lo AC, Nadeau S, Peixoto AJ, Gorman M, Boice JL, Concato J, Bravata DM. Derivation and validation of a clinical system for predicting pneumonia in acute stroke. Neuroepidemiology. 2011 Jul 28; 34(4):193-9.
  113. Restrepo MI, Mortensen EM, Anzueto A. Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? European Respiratory Journal. 2011 Jul 1; 38(1):1-3.
  114. Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2011 Jun 1; 15(6):e382-7.
  115. Miller MA, Arndt JL, Konkle MA, Chenoweth CE, Iwashyna TJ, Flaherty KR, Hyzy RC. A polyurethane cuffed endotracheal tube is associated with decreased rates of ventilator-associated pneumonia. Journal of Critical Care. 2011 Jun 1; 26(3):280-6.
  116. Mortensen EM. Potential causes of increased long-term mortality after pneumonia. [Editorial]. European Respiratory Journal. 2011 Jun 1; 37(6):1306-7.
  117. Fine MJ. The pneumonia severity index: from derivation to implementation. Presented at: Swiss Society for Internal Medicine Annual Meeting; 2011 May 13; Lausanne, Switzerland.
  118. Hanks D. HSR&D Stories-d, Improving Influenza and Pneumonia Vaccination among Veterans. 2011 May 10; 1(4).
  119. Lee JS, Primack BA, Mor MK, Stone RA, Obrosky DS, Yealy DM, Fine MJ. Does performance of evidence-based processes of care improve survival for patients with community-acquired pneumonia? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2011 May 4; Phoenix, AZ.
  120. Sanz F, Restrepo MI, Fernández E, Mortensen EM, Aguar MC, Cervera A, Chiner E, Blanquer J, Neumonía Adquirida en la Comunidad de la Comunidad Valenciana Study Group. Hypoxemia adds to the CURB-65 pneumonia severity score in hospitalized patients with mild pneumonia. Respiratory Care. 2011 May 1; 56(5):612-8.
  121. Walkey AJ, O'Donnell MR, Wiener RS. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials. Chest. 2011 May 1; 139(5):1148-55.
  122. Restrepo MI, Velez MI, Serna G, Anzueto A, Mortensen EM. Antimicrobial resistance in Hispanic patients hospitalized in San Antonio, TX with community-acquired pneumonia. Hospital practice (1995). 2010 Nov 1; 38(4):108-13.
  123. Garcia S, Mortensen EM, Leykum L, Nakashima B, Restrepo MI, Anzueto AR. Association of hypoglycemia for mortality in subjects hospitalized with pneumonia. Journal of hospital medicine. 2010 Oct 1; 5(3S2):S29-S29.
  124. Hsu JL, Siroka AM, Smith MW, Holodniy UG, Meduri UG. One-Year Outcomes of Community-Acquired and Health Care-Associated Pneumonia in the Veterans Affairs Health Care System. Poster session presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 2010 Sep 12; San Francisco, CA.
  125. Chang A, Walter LC. Recognizing dementia as a terminal illness in nursing home residents: Comment on "Survival and comfort after treatment of pneumonia in advanced dementia". Archives of internal medicine. 2010 Jul 12; 170(13):1107-9.
  126. Frei CR, Mortensen EM, Copeland LA, Attridge RT, Pugh MJ, Restrepo MI, Anzueto A, Nakashima B, Fine MJ. Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study. BMC health services research. 2010 May 27; 10:143.
  127. Cecere LM, Sun H, Bryson CL, Bradley KA, Williams E, Au DH. The Association between Smoking Cessation and Risk of Hospitalization for Pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2010 May 15; New Orleans, LA.
  128. Hsu DJ, Stone RA, Obrosky DS, Yealy DM, Meehan TP, Fine JM, Graff LG, Fine MJ. Predictors of timely antibiotic administration for patients hospitalized with community-acquired pneumonia from the cluster-randomized EDCAP trial. The American journal of the medical sciences. 2010 Apr 1; 339(4):307-13.
  129. Restrepo MI, Mortensen EM, Rello J, Brody J, Anzueto A. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest. 2010 Mar 1; 137(3):552-7.
  130. Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Archives of internal medicine. 2010 Feb 22; 170(4):347-53.
  131. Joo MJ, Au DH, Fitzgibbon ML, Lee TA. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respiratory medicine. 2010 Feb 1; 104(2):246-52.
  132. Parada JP, Yarnold PR, Uphold CR, Chmiel JS, DeHovitz JA, Goetz MB, Weinstein RA, McKoy JM, Chandler KL, Bennett CL. Racial variations in care and outcomes for inpatient HIV-related pneumocystis pneumonia. Journal of health care for the poor and underserved. 2010 Feb 1; 21(1):318-33.
  133. Rueda AM, Ormond M, Gore M, Matloobi M, Giordano TP, Musher DM. Hyperglycemia in diabetics and non-diabetics: effect on the risk for and severity of pneumococcal pneumonia. The Journal of Infection. 2010 Feb 1; 60(2):99-105.
  134. Bossi KE. Publication eBriefs-3, Jan 10, Pneumonia, Substance Use, Falls, Mental Health, Cancer. 2010 Jan 22; 2(3).
  135. Mortensen EM, Copeland LA, Pugh MJ, Fine MJ, Nakashima B, Restrepo MI, de Molina RM, Anzueto A. Diagnosis of pulmonary malignancy after hospitalization for pneumonia. The American journal of medicine. 2010 Jan 1; 123(1):66-71.
  136. South B, Gundlapalli A, Kim B, DuVall SL, Samore MH, Delisle S. Automated Classification of Pneumonia Cases using Chest X-Ray Reports for Hospital and Public Health Surveillance. Poster session presented at: International Society for Disease Surveillance Annual Conference; 2009 Dec 3; Miami, FL.
  137. South B, Gundlapalli A, Kim B, DuVall SL, Samore MH, Delisle S. Identifying Pneumonia Cases using Chest X-Ray Reports for Hospital and Public Health Surveillance. Paper presented at: International Society for Disease Surveillance Annual Conference; 2009 Dec 3; Miami, FL.
  138. Aujesky D, McCausland JB, Whittle J, Obrosky DS, Yealy DM, Fine MJ. Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Nov 15; 49(10):e100-8.
  139. Renaud B, Santin A, Coma E, Camus N, Van Pelt D, Hayon J, Gurgui M, Roupie E, Hervé J, Fine MJ, Brun-Buisson C, Labarère J. Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia. Critical care medicine. 2009 Nov 1; 37(11):2867-74.
  140. Rodriguez KL, Burkitt KH, Sevick MA, Obrosky DS, Aspinall SL, Switzer G, Mor MK, Fine MJ. Assessing processes of care to promote timely initiation of antibiotic therapy for emergency department patients hospitalized for pneumonia. Joint Commission Journal on Quality and Patient Safety. 2009 Oct 1; 35(10):509-18.
  141. Madaras K, Remington RE, Fan VS, Sloan KL. How Often is a Microbial Etiology Identified in Health Care-Associated Pneumonia (HCAP)? Poster session presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 2009 Sep 13; San Francisco, CA.
  142. Hausmann LR, Ibrahim SA, Mehrotra A, Nsa W, Bratzler DW, Mor MK, Fine MJ. Racial and ethnic disparities in pneumonia treatment and mortality. Medical care. 2009 Sep 1; 47(9):1009-17.
  143. Bean-Mayberry B, Yano EM, Mor MK, Bayliss NK, Xu X, Fine MJ. Does sex influence immunization status for influenza and pneumonia in older veterans? Journal of the American Geriatrics Society. 2009 Aug 1; 57(8):1427-32.
  144. Malo de Molina R, Mortensen EM, Restrepo MI, Copeland LA, Pugh MV, Anzueto A. Outpatient Inhaled Corticosteroid (ICS) therapy decreases mortality in patients with Chronic Obstructive Pulmonary Disease (COPD) and pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2009 May 15; San Diego, CA.
  145. Cella ND, Radcliff TA, Oman K, Linnebur S, Fish D, Ruscin JM, Liebrecht D, McNulty M, Fish R, Hutt EA. Impact of Chest X-ray Findings on Antibiotic Ordering Behavior in Nursing Home Acquired Pneumonia. Presented at: American Geriatrics Society Annual Meeting; 2009 Apr 29; Chicago, IL.
  146. Linnebur S, Fish D, Ruscin JM, Radcliff TA, Oman K, Liebrecht D, McNulty M, Hutt EA. Impact of Educational Interventions Targeting Antibiotic Use for Nursing Home-Acquired Pneumonia (NHAP). Presented at: American Geriatrics Society Annual Meeting; 2009 Apr 29; Chicago, IL.
  147. Frei CR, Jaso TC, Mortensen EM, Restrepo MI, Raut MK, Oramasionwu CU, Ruiz AD, Makos BR, Ruiz JL, Attridge RT, Mody SH, Fisher A, Schein JR. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study. Current Medical Research and Opinion. 2009 Apr 1; 25(4):859-68.
  148. Renaud B, Coma E, Santin A, Hayon J, Gurgui M, Camus N, Roupie E, Salloum M, Fine MJ, Brun-Buisson C, Labarère J, Hémery F, Hervé J. Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Critical Care (London, England). 2009 Jan 1; 13(2):R54.
  149. Restrepo MI, Mortensen EM, Waterer GW, Wunderink RG, Coalson JJ, Anzueto A. Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. European Respiratory Journal. 2009 Jan 1; 33(1):153-9.
  150. Srivastava R, Downey EC, O'Gorman M, Feola P, Samore M, Holubkov R, Mundorff M, James BC, Rosenbaum P, Young PC, Dean JM. Impact of fundoplication versus gastrojejunal feeding tubes on mortality and in preventing aspiration pneumonia in young children with neurologic impairment who have gastroesophageal reflux disease. Pediatrics. 2009 Jan 1; 123(1):338-45.
  151. Stupka JE, Mortensen EM, Anzueto A, Restrepo MI. Community-acquired pneumonia in elderly patients. Aging health. 2009 Jan 1; 5(6):763-774.
  152. Hutt EA, Corbett KK, Bent K, Ruscin JM, Williams EM. Challenges to Implementing Guidelines for Treating Nursing Home-Acquired Pneumonia: A Qualitative Assessment of Variation in Five Settings. Presented at: VA QUERI National Meeting; 2008 Dec 10; Phoenix, AZ.
  153. Aujesky D, Fine MJ. Community-acquired pneumonia: treatment at home or in the hospital? The American journal of medicine. 2008 Dec 1; 121(12):1038-40.
  154. Aujesky D, Fine MJ. The pneumonia severity index: a decade after the initial derivation and validation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Dec 1; 47 Suppl 3:S133-9.
  155. Díaz LA, Mortensen EM, Anzueto A, Restrepo MI. Novel targets in the management of pneumonia. Therapeutic Advances in Respiratory Disease. 2008 Dec 1; 2(6):387-400.
  156. Mortensen EM, Restrepo MI, Copeland LA, Pugh JA, Anzueto A. Association of hydrophilic versus lipophilic angiotensin-converting enzyme inhibitor use on pneumonia-related mortality. The American journal of the medical sciences. 2008 Dec 1; 336(6):462-6.
  157. Mortensen EM, Restrepo MI, Pugh JA, Anzueto A. Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study. BMC Res Notes. 2008 Dec 1; 1:120.
  158. Malo de Molina R, Mortensen EM, Castellanos-Matteus P, Anzueto A, Restrepo MI. The impact of outpatient inhaled corticosteroid therapy on disease severity in hospitalized patients with community acquired pneumonia. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2008 Oct 25; Philadelphia, PA.
  159. Malo de Molina R, Mortensen EM, Restrepo MI, Castellanos-Matteus P, Anzueto A. Impact of pulmonary arterial hypertension (PAH) in patients hospitalized with community acquired pneumonia (CAP) or sepsis. Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2008 Oct 25; Philadelphia, PA.
  160. Restrepo MI, Mortensen EM, Shorr AF, Zilberberg MD, Kollef MH, Anzueto A. Understanding the health care-associated pneumonia (HCAP) definition. Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2008 Oct 25; Philadelphia, PA.
  161. Coffin SE, Klompas M, Classen D, Arias KM, Podgorny K, Anderson DJ, Burstin H, Calfee DP, Dubberke ER, Fraser V, Gerding DN, Griffin FA, Gross P, Kaye KS, Lo E, Marschall J, Mermel LA, Nicolle L, Pegues DA, Perl TM, Saint S, Salgado CD, Weinstein RA, Wise R, Yokoe DS. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2008 Oct 1; 29 Suppl 1:S31-40.
  162. Hutt E, Radcliff TA, Liebrecht D, Fish R, McNulty M, Kramer AM. Associations among nurse and certified nursing assistant hours per resident per day and adherence to guidelines for treating nursing home-acquired pneumonia. The journals of gerontology. Series A, Biological sciences and medical sciences. 2008 Oct 1; 63(10):1105-11.
  163. Krein SL, Kowalski CP, Damschroder L, Forman J, Kaufman SR, Saint S. Preventing ventilator-associated pneumonia in the United States: a multicenter mixed-methods study. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2008 Oct 1; 29(10):933-40.
  164. Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, Harris AD. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC infectious diseases. 2008 Sep 15; 8:116.
  165. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, Restrepo MI, Auger WR, Schinner R, NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA : the journal of the American Medical Association. 2008 Aug 20; 300(7):805-13.
  166. Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Aug 1; 47(3):375-84.
  167. Restrepo MI, Mortensen EM, Waterer GW, Wunderink RG, Anzueto A. Macrolides in Severe Community-Acquired Pneumonia and Sepsis. In: Sepsis: New Strategies for Management. Berlin & Heidelberg, Germany: Springer Verlag; 2008. Chapter 1. 1-18 p.
  168. Tobia CC, Aspinall SL, Good CB, Fine MJ, Hanlon JT. Appropriateness of antibiotic prescribing in veterans with community-acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clinical therapeutics. 2008 Jun 1; 30(6):1135-44.
  169. Mortensen EM, Restrepo MI, Pugh JA, Anzueto AR. Impact of prior outpatient antibiotic use on mortality for patients hospitalized with community-acquired pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 16; Toronto, Canada.
  170. Restrepo MI , Mortensen EM, Castellanos-Matteus P, Malo de Molina R , Anzueto A. Macrolide resistance does not affect the survival benefit of macrolides in pneumonia patients with severe sepsis. Paper presented at: American Thoracic Society Annual International Conference; 2008 May 16; Toronto, Canada.
  171. Sanchez JF, Mortensen EM, Anzueto A, Restrepo MI. Validation of the minor ATS/IDSA criteria on mortality and ICU admission in patients with severe pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 16; Toronto, Canada.
  172. Mortensen EM, Restrepo MI, Anzueto A. When to switch therapy in patients with severe community-acquired pneumonia. [Letter to the Editor]. Annals of internal medicine. 2008 Apr 15; 148(8):625; author reply 625-6.
  173. Krein SL, Kowalski, Kaufman, Forman, Damschroder, Saint. Preventing Ventilator-Associated Pneumonia in U.S. Hospitals: A Mixed Methods Study. Paper presented at: Society for Healthcare Epidemiology of America Scientific Annual Meeting; 2008 Apr 7; Orlando, FL.
  174. Mortensen EM, Restrepo MI, Copeland LA, Anzueto AR, Pugh MJ. Association of lipophilic and hydrophilic ACE inhibitor use with pneumonia-related mortality. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 1; Pittsburgh, PA.
  175. Mortensen EM, Restrepo MI, Pugh JA, Anzueto AR. Impact of prior outpatient antibiotic use on mortality for patients hospitalized for community-acquired pneumonia. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 1; Pittsburgh, PA.
  176. Mortensen EM, Pugh MJ, Copeland LA, Restrepo MI, Cornell JE, Anzueto A, Pugh JA. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia. European Respiratory Journal. 2008 Mar 1; 31(3):611-7.
  177. Restrepo MI, Bienen T, Mortensen EM, Anzueto A, Metersky ML, Escalante P, Wunderink RG, Mangura BT, Chest Infections Network. Evaluation of ICU admission criteria and diagnostic methods for patients with severe community-acquired pneumonia: current practice survey. [Letter to the Editor]. Chest. 2008 Mar 1; 133(3):828-9.
  178. Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Feb 15; 46(4):550-6.
  179. Fine MJ. The Pneumonia Severity Index: a decade after development. Paper presented at: Infectious Diseases Society of America / Federal Drug Administration Community-Acquired Pneumonia Annual Workshop; 2008 Jan 17; Silver Spring, MD.
  180. Gould CV, Sniegowski PD, Shchepetov M, Metlay JP, Weiser JN. Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis. Antimicrobial agents and chemotherapy. 2007 Sep 1; 51(9):3225-9.
  181. Hennessy S, Bilker WB, Leonard CE, Chittams J, Palumbo CM, Karlawish JH, Yang YX, Lautenbach E, Baine WB, Metlay JP. Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. Journal of clinical epidemiology. 2007 Sep 1; 60(9):911-8.
  182. Renaud B, Coma E, Hayon J, Gurgui M, Longo C, Blancher M, Jouannic I, Betoulle S, Roupie E, Fine MJ, PNEUMOCOM study investigators. Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study. Clinical Microbiology and Infection : The Official Publication of The European Society of Clinical Microbiology and Infectious Diseases. 2007 Sep 1; 13(9):923-31.
  183. Nolt BR, Gonzales R, Maselli J, Aagaard E, Camargo CA, Metlay JP. Vital-sign abnormalities as predictors of pneumonia in adults with acute cough illness. The American journal of emergency medicine. 2007 Jul 1; 25(6):631-6.
  184. Pines JM, Hollander JE, Lee H, Everett WW, Uscher-Pines L, Metlay JP. Emergency department operational changes in response to pay-for-performance and antibiotic timing in pneumonia. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2007 Jun 1; 14(6):545-8.
  185. Yealy DM, Auble TE, Fine MJ. Using the pneumonia severity index to guide hospitalization decisions. The American journal of medicine. 2007 Jun 1; 120(6):e21.
  186. Hutt E, Radcliff T, Liebrecht D, Fish R, McNulty M, Kramer A. Nursing Home-Acquired Pneumonia Treatment Guideline Adherence is Associated with Nurse Staffing Ratios and Turnover. Paper presented at: American Geriatrics Society Annual Meeting; 2007 May 2; Seattle, WA.
  187. Mortensen EM, Restrepo M, Copeland LA, Anzueto AR, Pugh JA. Association of lipophilic and hydrophilic ACE inhibitors with pneumonia-related mortality. Presented at: American Thoracic Society Annual International Conference; 2007 May 1; San Francisco, CA.
  188. Díaz A, Barria P, Niederman M, Restrepo MI, Dreyse J, Fuentes G, Couble B, Saldias F. Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest. 2007 Mar 1; 131(3):779-87.
  189. Kyriacou DN, Yarnold PR, Stein AC, Schmitt BP, Soltysik RC, Nelson RR, Frerichs RR, Noskin GA, Belknap SM, Bennett CL. Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. 2007 Feb 1; 131(2):489-96.
  190. Labarere J, Stone RA, Obrosky DS, Yealy DM, Meehan TP, Fine JM, Graff LG, Fine MJ. Comparison of outcomes for low-risk outpatients and inpatients with pneumonia: a propensity-adjusted analysis. Chest. 2007 Feb 1; 131(2):480-8.
  191. Lee TA, Weaver FM, Weiss KB. Impact of Pneumococcal Vaccination on Pneumonia Rates in Patients with COPD and Asthma. Journal of general internal medicine. 2007 Jan 1; 22(1):62-7.
  192. Renaud B, Coma E, Labarere J, Hayon J, Roy PM, Boureaux H, Moritz F, Cibien JF, Guérin T, Carré E, Lafontaine A, Bertrand MP, Santin A, Brun-Buisson C, Fine MJ, Roupie E. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Jan 1; 44(1):41-9.
  193. Restrepo MI, Anzueto A. The role of new therapies for severe community-acquired pneumonia. Current opinion in infectious diseases. 2006 Dec 1; 19(6):557-64.
  194. Velez JA, Mortensen EM, Anzueto A, Restrepo MI. Antimicrobial treatment of community-acquired pneumonia in the elderly. Aging health. 2006 Dec 1; 2(6):999-1011.
  195. Hutt E, Ruscin JM, Corbett K, Radcliff TA, Kramer AM, Williams EM, Liebrecht D, Klenke W, Hartmann S. A multifaceted intervention to implement guidelines improved treatment of nursing home-acquired pneumonia in a state veterans home. Journal of the American Geriatrics Society. 2006 Nov 1; 54(11):1694-700.
  196. Mortensen. Impact of statins in patients with pneumonia and sepsis. Presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2006 Oct 21; Salt Lake City, UT.
  197. Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. The American journal of medicine. 2006 Oct 1; 119(10):865-71.
  198. Hutt E. Improving Care for Nursing Home Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Mountain West Regional Annual Meeting; 2006 Sep 1; Aspen, CO.
  199. Metlay JP, Fishman NO, Joffe MM, Kallan MJ, Chittams JL, Edelstein PH. Macrolide resistance in adults with bacteremic pneumococcal pneumonia. Emerging Infectious Diseases. 2006 Aug 1; 12(8):1223-30.
  200. Pines JM, Hollander JE, Localio AR, Metlay JP. The association between emergency department crowding and hospital performance on antibiotic timing for pneumonia and percutaneous intervention for myocardial infarction. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2006 Aug 1; 13(8):873-8.
  201. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. European Respiratory Journal. 2006 Aug 1; 28(2):346-51.
  202. Hutt E, Rumsfeld JS, Kramer AM, Williams EM, Liebrecht D, Klenke W, Hartmann S. A Multifaceted Intervention to Implement Guidelines Improved Treatment of Nursing Home-Acquired Pneumonia in a State Veterans Home. Paper presented at: Agency for Healthcare Research and Quality Translating Research Into Practice and Policy Annual Meeting; 2006 Jul 1; Washington, DC.
  203. Labarere J, Stone RA, Scott Obrosky D, Yealy DM, Meehan TP, Auble TE, Fine JM, Graff LG, Fine MJ. Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial. Journal of general internal medicine. 2006 Jul 1; 21(7):745-52.
  204. Fine MJ. Ensuring timely administration of antibiotic therapy for patients with community-acquired pneumonia in the VA Healthcare System [plenary talk]. Paper presented at: VA Optimizing Clinical Performance Through Systems Management Conference; 2006 Jun 6; Phoenix, AZ.
  205. Aspinall SL, Hyman KB, Fine MJ. Ensuring timely administration of antibiotic therapy for patients with community-acquired pneumonia. Paper presented at: VA VISN Formulary Leaders Meeting; 2006 May 17; Chicago, IL.
  206. Barnett MJ, Perry PJ, Alexander B, Kaboli PJ. Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients. Journal of Clinical Psychopharmacology. 2006 Apr 1; 26(2):182-7.
  207. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest. 2006 Apr 1; 129(4):968-78.
  208. Obrosky DS, Edick SM, Fine MJ. The emergency department triage of community-acquired pneumonia project data and documentation systems: a model for multicenter clinical trials. IEEE Transactions On Information Technology in Biomedicine : A Publication of The Ieee Engineering in Medicine and Biology Society. 2006 Apr 1; 10(2):377-84.
  209. Flanders SA, Collard HR, Saint S. Nosocomial pneumonia: state of the science. American journal of infection control. 2006 Mar 1; 34(2):84-93.
  210. Tejerina E, Frutos-Vivar F, Restrepo MI, Anzueto A, Abroug F, Palizas F, Gonzalez M, D'Empaire G, Apezteguia C, Esteban A. Incidence, risk factors, and outcome of ventilator-associated pneumonia. Journal of Critical Care. 2006 Mar 1; 21(1):56-65.
  211. Mortensen EM, Pugh MJ, Cornell J, Copeland LA, Restrepo MI, Pugh JA. Impact of prior statin use on mortality for patients hospitalized with community-acquired pneumonia. Paper presented at: VA HSR&D National Meeting; 2006 Feb 1; Arlington, VA.
  212. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum. 2006 Feb 1; 54(2):628-34.
  213. Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine. 2006 Jan 23; 24(4):468-75.
  214. Anzueto A, Niederman MS, Pearle J, Restrepo MI, Heyder A, Choudhri SH. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Jan 1; 42(1):73-81.
  215. Furuno JP, Metlay JP, Harnett JP, Wilson J, Langenberg P, McGregor JC, Zhu J, Perencevich EN. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Pharmacoepidemiology and drug safety. 2006 Jan 1; 15(1):1-9.
  216. Velez JA, Mortensen EM, Anzueto A, Restrepo MI. Analisis de severidad y criterios de hospitalizacion en pacientes con neumonia adquirida en la comunidad [Severity of illness analysis and hospitalization criteria for patients with community-acquired pneumonia]. Revista CES Medicina. 2006 Jan 1; 20(1):15-23.
  217. Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, Fine JM, Obrosky DS, Mor MK, Whittle J, Fine MJ. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Annals of internal medicine. 2005 Dec 20; 143(12):881-94.
  218. Frei C, Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Validation of guideline-concordant empiric antibiotic therapy for ICU patients with community-acquired pneumonia. Paper presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy / Infectious Diseases Society of America Joint Meeting; 2005 Dec 16; Washington, DC.
  219. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The impact of empiric antimicrobial therapy with a ß-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Critical Care (London, England). 2005 Dec 6; 10(1):R8.
  220. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Impact of guideline-concordant antibiotic therapy on mortality within 48 hours of admission for patients hospitalized with community-acquired pneumonia / Chest. Paper presented at: American College of Surgeons Spring Meeting; 2005 Oct 31; Montréal, Canada.
  221. Restrepo MI, Anzueto A, Mortensen EM, Pugh JA, Metersky ML, Escalante P, Wunderink RG, Mangura BT. Evaluation of ICU admission criteria for patients with community-acquired pneumonia: current practice survey / Chest. Poster session presented at: American College of Surgeons Spring Meeting; 2005 Oct 31; Montréal, Canada.
  222. Frei C, Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Impact of guideline concordant empiric antibiotic therapy in hospitalized patients with community-acquired pneumonia. Paper presented at: Infectious Diseases Society of America Annual Meeting; 2005 Oct 6; San Francisco, CA.
  223. Cooper GF, Abraham V, Aliferis CF, Aronis JM, Buchanan BG, Caruana R, Fine MJ, Janosky JE, Livingston G, Mitchell T, Monti S, Spirtes P. Predicting dire outcomes of patients with community acquired pneumonia. Journal of Biomedical Informatics. 2005 Oct 1; 38(5):347-66.
  224. Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 Oct 1; 41(7):923-9.
  225. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Critical care medicine. 2005 Oct 1; 33(10):2184-93.
  226. Aujesky D, Fine MJ. Does guideline adherence for empiric antibiotic therapy reduce mortality in community-acquired pneumonia [editorial]. [Editorial]. American journal of respiratory and critical care medicine. 2005 Sep 15; 172(6):655-656.
  227. Restrepo MI, Angel LF, Mortensen EM, Anzueto A. Steroid infusion for severe pneumonia: not so fast... American journal of respiratory and critical care medicine. 2005 Sep 15; 172(6):781; author reply 782-3.
  228. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC pulmonary medicine. 2005 Sep 13; 5:12.
  229. Tejerina E, Frutos-Vivar F, Restrepo MI, Anzueto A, Palizas F, Gonzalez M, Apezteguia C, Abroug F, Matamis D, Bugedo G, Esteban A. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation. Journal of Critical Care. 2005 Sep 1; 20(3):230-8.
  230. Stone RA, Mor MK, Lave JR, Hough LJ, Fine MJ. Implementation of an inpatient management and discharge strategy for patients with community-acquired pneumonia. The American journal of managed care. 2005 Aug 1; 11(8):491-9.
  231. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respiratory Research. 2005 Jul 25; 6:82.
  232. Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 Jul 1; 41(1):21-9.
  233. Halm EA, Fine MJ. Community-acquired pneumonia. In: Wachter, Goldman, Hollander, editors. Hospital Medicine. 2 ed. Baltimore, MD: Lippincott-Williams & Wilkins; 2005.
  234. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Evaluation of predictive tools to define need for ICU in patients with community-acquired pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2005 May 20; San Diego, CA.
  235. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Quality of care in intensive care unit patients with severe community-acquired pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2005 May 20; San Diego, CA.
  236. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. The association between systemic steroid use and mortality in patients hospitalized with community-acquired pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2005 May 20; San Diego, CA.
  237. Lee TA, Xu J, Weaver FM, Weiss KB. Risk of Pneumonia-Related Hospitalizations in Patients with Chronic Lung Disease. Poster session presented at: American Thoracic Society Annual International Conference; 2005 May 1; San Diego, CA.
  238. McCausland JB, Auble TE, Whittle J, Obrosky DS, Yealy DM, Fine MJ. Clinician-reported barriers for admission of low risk and discharge of higher risk patients with pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2005 May 1; New Orleans, LA.
  239. Renaud B, Coma E, Labarere J, Hayon J, Longo C, Blancher M, Fine MJ, Roupe E. Effectiveness and safety of using the pneumonia severity index to triage patients with pneumonia in the emergency department: a multicenter European study. Paper presented at: Society of General Internal Medicine Annual Meeting; 2005 May 1; New Orleans, LA.
  240. Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. The American journal of medicine. 2005 Apr 1; 118(4):384-92.
  241. Aujesky D, Stone RA, Obrosky DS, Yealy DM, Auble TE, Meehan TP, Graff LG, Fine JM, Fine MJ. Using randomized controlled trial data, the agreement between retrospectively and prospectively collected data comprising the pneumonia severity index was substantial. Journal of clinical epidemiology. 2005 Apr 1; 58(4):357-63.
  242. Restrepo MI, Anzueto A. Antimicrobial treatment of community-acquired pneumonia. Clinics in Chest Medicine. 2005 Mar 1; 26(1):65-73.
  243. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. Differences in length of stay for patients with community-acquired pneumonia. Poster session presented at: VA HSR&D National Meeting; 2005 Feb 16; Baltimore, MD.
  244. Restrepo M, Mortensen EM, Anzueto A, Pugh J. Evaluation of predictive tools to define need for ICU in patients with community-acquired pneumonia. Paper presented at: VA HSR&D National Meeting; 2005 Feb 16; Baltimore, MD.
  245. Chang HT, Evans CT, Weaver FM, Burns SP, Parada JP. Etiology and outcomes of veterans with spinal cord injury and disorders hospitalized with community-acquired pneumonia. Archives of physical medicine and rehabilitation. 2005 Feb 1; 86(2):262-7.
  246. Lee TA, Xu J, Weaver FM, Weiss KB. Risk of Pneumonia-Related Hospitalizations in Patients with Chronic Lung Disease. Poster session presented at: VA HSR&D National Meeting; 2005 Feb 1; Baltimore, MD.
  247. Dezfulian C, Shojania K, Collard HR, Kim HM, Matthay MA, Saint S. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. The American journal of medicine. 2005 Jan 1; 118(1):11-8.
  248. Metlay JP. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia. Infectious Disease Clinics of North America. 2004 Dec 1; 18(4):777-90.
  249. Mortensen EM, Restrepo M, Anzueto A, Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. The American journal of medicine. 2004 Nov 15; 117(10):726-31.
  250. Klugman KP, Low DE, Metlay J, Pechere JC, Weiss K. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities. International Journal of Antimicrobial Agents. 2004 Nov 1; 24(5):411-422.
  251. Restrepo MI, Mortensen EM, Anzueto A. Community-Acquired Pneumonia (International Version). In: Ortiz-Ruiz G, Perafan MA, Faist E, editors. Sepsis. New York, NY: Springer-Verlag; 2004. Chapter 4. 41-52 p.
  252. Restrepo MI, Mortensen EM, Waratunge N, Pugh JA, Anzueto A. Should All Bacteremic Pneumococcal Pneumonia Patients Be Considered Severe Community-Acquired Pneumonia? Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2004 Oct 27; Seattle, WA.
  253. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. The Association between Statin Use and Mortality for Patients Hospitalized with Community-Acquired Pneumonia. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2004 Oct 26; Seattle, WA.
  254. Mortensen EM, Cornell J, Whittle J. Racial variations in processes of care for patients with community-acquired pneumonia. BMC health services research. 2004 Aug 10; 4(1):20.
  255. Burns SP, Weaver FM, Parada JP, Evans CT, Chang H, Hampton RY, Kapur V. Management of community-acquired pneumonia in persons with spinal cord injury. Spinal Cord. 2004 Aug 1; 42(8):450-8.
  256. McBean AM, Hebert PL. New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2004 Jul 1; 8(4):227-35.
  257. Yealy DM, Auble TE, Stone RA, Lave JR, Meehan TP, Graff LG, Fine JM, Obrosky DS, Edick SM, Hough LJ, Tuozzo K, Fine MJ. The emergency department community-acquired pneumonia trial: Methodology of a quality improvement intervention. Annals of Emergency Medicine. 2004 Jun 1; 43(6):770-82.
  258. Aujesky DA, Stone RA, Obrosky DS, Yealy DM, Auble TE, Fine MJ. How good is the agreement between prospectively and retrospectively collected data comprising the pneumonia severity index. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 12; Chicago, IL.
  259. McCausland JB, Yealy DM, Fine MJ. The agree instrument: critical appraisal of community-acquired pneumonia guidelines by physicians. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 12; Chicago, IL.
  260. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. The Association between Statin and ACE Inhibitor Use and Mortality for Patients Hospitalized with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 11; Chicago, IL.
  261. Fine MJ, Auble TE, Stone RA. The Emergency Department Community-Acquired Pneumonia (EDCAP) trial: effectiveness of guideline implementation strategies to improve initial quality of care. Paper presented at: Society of General Internal Medicine Annual Meeting; 2004 May 2; Chicago, IL.
  262. Metlay JP. Risk factors for drug resistant pneumococcal pneumonia. Paper presented at: Pneumococci and Pneumococcal Diseases International Annual Symposium; 2004 May 1; Helsinki, Finland.
  263. Shutt CK, Samore M, Carroll KC. Comparison of the Denka Seiken slide agglutination method to the quellung test for serogrouping of Streptococcus pneumoniae isolates. Journal of clinical microbiology. 2004 Mar 1; 42(3):1274-6.
  264. Sureka A, Parada JP, Deloria-Knoll M, Chmiel JS, Phan L, Lyons TM, Ali S, Yarnold PR, Weinstein RA, Dehovitz JA, Jacobson JM, Goetz MB, Campo RE, Berland D, Bennett CL, Uphold CR. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care and Stds. 2004 Feb 1; 18(2):99-107.
  265. Uphold CR, Deloria-Knoll M, Palella FJ, Parada JP, Chmiel JS, Phan L, Bennett CL. US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. 2004 Feb 1; 125(2):548-56.
  266. Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2003 Dec 15; 37(12):1617-24.
  267. Parada JP, Deloria-Knoll M, Chiel J, Arozullah AM, Phan L, Yarnold PR, Bennett CL. Medicaid, money, and mortality in HIV-related pneumonia. Paper presented at: Chicago Health Services Research Council Annual Consortium; 2003 Dec 1; Chicago, IL.
  268. Parada JP, Deloria-Knoll M, Chmiel JS, Arozullah AM, Phan L, Ali SN, Goetz MB, Weinstein RA, Campo R, Jacobson J, Dehovitz J, Berland D, Bennett CL. Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2003 Dec 1; 37(11):1549-55.
  269. Restrepo MI, Mortensen EM, Anzueto A, Pugh JA. Mortality in Monotherapy versus Combination Therapy in Severe Community-Acquired Pneumonia: A Systematic Review. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2003 Oct 29; Orlando, FL.
  270. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. Is Combination Therapy Needed in Hospitalized Patients with Community-Acquired Pneumonia? Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2003 Oct 29; Orlando, FL.
  271. Chang HT, Evans CT, Weaver FM, Burns SP, Parada JP. Etiology and outcomes of Veterans with spinal cord injury hospitalized and community acquired-pneumonia. Paper presented at: Loyola University Chicago Stritch School of Medicine Annual Forum; 2003 Oct 1; Maywood, IL.
  272. Fine MJ, Stone RA, Lave JR, Hough LJ, Obrosky DS, Mor MK, Kapoor WN. Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial. The American journal of medicine. 2003 Oct 1; 115(5):343-51.
  273. Switzer GE, Halm EA, Chang CC, Mittman BS, Walsh MB, Fine MJ. Physician awareness and self-reported use of local and national guidelines for community-acquired pneumonia. Journal of general internal medicine. 2003 Oct 1; 18(10):816-23.
  274. Restrepo MI, Mortensen EM, Anzueto A, Pugh JA. Short-Term Mortality with Fluroquinolone Monotherapy versus Combination Therapy in Severe Community-acquired Pneumonia: A Systematic Review. Paper presented at: Infectious Diseases Society of America Annual Meeting; 2003 Sep 1; San Diego, CA.
  275. Weaver FM, Goldstein B, Legro M. Increasing influenza and pneumococcal pneumonia vaccinations in VA SCI&D. Paper presented at: American Paraplegia Society Annual Meeting; 2003 Sep 1; Las Vegas, NV.
  276. Weaver FM, Goldstein B, Legro M. National Vaccine Project: Increasing Influenza and Pneumococcal Pneumonia Vaccinations in VA SCI. Paper presented at: American Paraplegia Society Annual Meeting; 2003 Sep 1; Las Vegas, NV.
  277. Metlay JP, Kinman JL. Failure to validate pneumococcal pneumonia diagnoses in the general practice research database. Paper presented at: Pharmacoepidemiology and Therapeutic Risk Management Annual International Conference; 2003 Aug 23; Philadelphia, PA.
  278. Aujesky D, Fine MJ. What are the predictors of short-term mortality in patients with community-acquired pneumonia. [Editorial]. The Journal of Respiratory Diseases. 2003 Jun 1; 24:190-192.
  279. Restrepo MI, Mortensen EM, Velez JA, Pugh JA, Anzueto A. Outcomes and Presentation of Extremely Elderly Patients with Community-Acquired Pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2003 May 16; Seattle, WA.
  280. Restrepo MI, Mortensen EM, Velez JA, Pugh JA, Anzueto A. Presentations and Outcomes in Hispanics with Community-Acquired Pneumonia (CAP). Paper presented at: American Thoracic Society Annual International Conference; 2003 May 16; Seattle, WA.
  281. Aujesky D, Auble TE, Yealy DM, Obrosky DS, Stone RA, Fine MJ. Predicting mortality in patients with community-acquired pneumonia: a comparison of 3 prognostic models. Paper presented at: Society of General Internal Medicine Annual Meeting; 2003 May 1; Vancouver, Canada.
  282. Restrepo MI, Adams SG, Jorgensen JH, Pugh JA, Anzueto A, Mortensen EM. Process of Care and Clinical Outcomes in COPD Patients with Community Acquired Pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2003 May 1; Seattle, WA.
  283. Arozullah AM, Parada J, Bennett CL, Deloria-Knoll M, Chmiel JS, Phan L, Yarnold PR. A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest. 2003 Apr 1; 123(4):1151-60.
  284. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Guideline-Concordant Antibiotic Therapy and Mortality for Patients with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2003 Apr 1; Vancouver, Canada.
  285. Parada JP. HIV/AIDS-Related Pneumocystis carinii Pneumonia, Medicaid, Bronchoscopy, & Survival. Paper presented at: VA Hines VAMC Research Annual Seminar; 2003 Apr 1; Hines, IL.
  286. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Annals of internal medicine. 2003 Mar 18; 138(6):494-501.
  287. Fowler RA, Flavin KE, Barr J, Weinacker AB, Parsonnet J, Gould MK. Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest. 2003 Mar 1; 123(3):835-44.
  288. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Guideline Concordant Antimicrobial Therapy and Mortality in Community-Acquired Pneumonia. Paper presented at: VA HSR&D National Meeting; 2003 Feb 13; Washington, DC.
  289. Parada JP, Deloria-Knott M, Phan L, Chmiel J, Arozullah AM, Bennett CL. Private vs. Public: Insurance Effects on Outcomes and Resource Utilization in HIV-Related Pneumonia. Paper presented at: VA HSR&D National Meeting; 2003 Feb 1; Washington, DC.
  290. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Annals of internal medicine. 2003 Jan 21; 138(2):109-18.
  291. Langmore SE, Skarupski KA, Park PS, Fries BE. Predictors of aspiration pneumonia in nursing home residents. Dysphagia. 2002 Dec 1; 17(4):298-307.
  292. Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Archives of internal medicine. 2002 Nov 25; 162(21):2469-77.
  293. Metlay JP. Streptococcus pneumoniae: emerging resistance and NCCLS breakpoints. Paper presented at: American Society for Microbiology / National Laboratory Training Network / Eastern Pennsylvania Branch Annual Meeting; 2002 Nov 14; Philadelphia, PA.
  294. Fine MJ, Yealy DM, Auble TE, Stone RA, Obrosky DS, Lave JR, Meehan TP, Fine JM, Graff LG. Translating the pneumonia severity index into clinical practice: results of a randomized trial to influence the admission decision. Paper presented at: International Society for Quality in Health Care Annual Meeting; 2002 Nov 5; Paris, France.
  295. Restrepo MI, Adams S, Jorgensen JH, Pugh JA, Anzueto A, Mortensen EM. Processes of Care (POC) in COPD Patients with Community-Acquired Pneumonia (CAP). Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2002 Nov 1; San Diego, CA.
  296. Restrepo MI, Mortensen EM, Jorgensen JH, Pugh JA, Anzueto A. Processes of care (POC) in COPD patients with severe community-acquired pneumonia (SCAP). Paper presented at: Infectious Diseases Society of America Annual Meeting; 2002 Oct 1; Chicago, IL.
  297. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremsizov TT, Coley C, Fine MJ, Singer DE, Kapoor WN. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. American journal of respiratory and critical care medicine. 2002 Sep 1; 166(5):717-23.
  298. Hutt E, Frederickson E, Ecord M, Kramer AM. Processes of care predict survival following nursing home-acquired pneumonia. Journal of clinical outcomes management : JCOM. 2002 Sep 1; 9(5):249-256.
  299. Parada JP, Lyons T, Deloria-Knott M, Ali S, Chmiel J, Bennett CL. HIV-related Pneumocystis carinii Pneumonia: Illicit Drug Use, Inpatient Care and Outcomes. Paper presented at: VA HIV Providers Annual Meeting; 2002 Sep 1; Chicago, IL.
  300. Parada JP, Sureka A, Deloria-Knott M, Bennett CL. HIV-related Pneumonia Care in Older Patients Hospitalized. Paper presented at: VA HIV Providers Annual Meeting; 2002 Sep 1; Chicago, IL.
  301. Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. Family Practice. 2002 Aug 1; 51(8):709-16.
  302. Moellering RC, Craig W, Edmond M, Farrell DJ, Ferraro MJ, File TM, Klein J, Lonks J, Metlay JP, Sahm D, Talbot GH. Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae. Journal of Chemotherapy (Florence, Italy). 2002 Jul 1; 14 Suppl 3:42-56.
  303. Halm EA, Fine MJ, Kapoor WN, Singer DE, Marrie TJ, Siu AL. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Archives of internal medicine. 2002 Jun 10; 162(11):1278-84.
  304. Restrepo MI, Mortensen EM, Jorgensen JH, Catano JC, Vasquez EM, Pugh JA, Anzueto A. Antimicrobial Therapy and Outcomes in Patients with Community-Acquired Pneumonia (CAP). Paper presented at: American Thoracic Society Annual International Conference; 2002 May 17; Atlanta, GA.
  305. Restrepo MI, Mortensen EM, Jorgensen JH, Catano JC, Vasquez EM, Pugh JA, Anzueto A. Process of Care (POC) for Patients with Severe Community-Acquired Pneumonia (CAP). Paper presented at: American Thoracic Society Annual International Conference; 2002 May 17; Atlanta, GA.
  306. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Archives of internal medicine. 2002 May 13; 162(9):1059-64.
  307. Yealy DM, Fine MJ, Auble TE, Stone RA, Lave JR, Meehan TP, Fine JM, Graff LG. Translating the pneumonia severity index into practice: a trial to influence the admission decision. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2002 May 9; 9(5):361.
  308. Mortensen EM, Cornell JE, Pederson T, Whittle J. Racial Variations in Processes of Care for Patients with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 May 1; Atlanta, GA.
  309. Restrepo MI, Mortensen EM, Jorgensen JH, Catano JC, Vasquez EM, Pugh JA. Clinical Outcomes in Patients with Community-Acquired Pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2002 May 1; Atlanta, GA.
  310. Fine JM, Fine MJ, Galusha D, Petrillo M, Meehan TP. Patient and hospital characteristics associated with recommended processes of care for elderly patients hospitalized with pneumonia: results from the Medicare quality indicator system pneumonia module. Archives of internal medicine. 2002 Apr 8; 162(7):827-33.
  311. Fine MJ, Yealy DM, Auble TE, Stone RA, Lave JR, Meechan TP, Graff LG. Translating the pneumonia severity index into practice: a trial to influence the admission decision. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 Apr 1; Atlanta, GA.
  312. Lautenbach E, Fishman NO, Metlay JP, Bilker WB, Edelstein PH, Strom BL. Fluoroquinolone resistance is independently associated with increased mortality in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Paper presented at: Society for Healthcare Epidemiology of America Scientific Annual Meeting; 2002 Apr 1; Salt Lake City, UT.
  313. Metlay JP. Update on community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes. Current opinion in infectious diseases. 2002 Apr 1; 15(2):163-7.
  314. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Underperformance of Processes of Care for Veterans Hospitalized with Community-Acquired Pneumonia. Paper presented at: VA HSR&D National Meeting; 2002 Feb 15; Washington, DC.
  315. Marrie TJ, Fine MJ, Kapoor WN, Coley CM, Singer DE, Obrosky DS. Community-acquired pneumonia and do not resuscitate orders. Journal of the American Geriatrics Society. 2002 Feb 1; 50(2):290-9.
  316. Fowler RA, Pearl RG, Gould MK. Clinical guidelines for the treatment of ventilator-associated pneumonia. Critical care medicine. 2002 Jan 1; 30(1):266.
  317. Restrepo MI, Jorgensen JH, Mortensen EM, Anzueto A. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy. Current opinion in infectious diseases. 2001 Dec 1; 14(6):703-9.
  318. Yealy DM, Auble TE, Fine MJ. Adult community-acquired pneumonia. In: Frank LR, Jobe KA, editors. Admission & Discharge. Philadelphia, PA: Hanley & Belfus; 2001.
  319. Arozullah AM, Khuri SF, Henderson WG, Daley J. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Annals of internal medicine. 2001 Nov 20; 135(10):847-57.
  320. Rhew DC, Goetz MB, Shekelle PG. Evaluating quality indicators for patients with community-acquired pneumonia. Joint Commission Journal on Quality Improvement. 2001 Nov 1; 27(11):575-90.
  321. Fowler R, Flavin K, Weinacker A, Barr J, Gould MK. Choice of initial empiric antibiotic therapy influences in-hospital survival for patients with ventilator-associated pneumonia. Critical care medicine. 2001 Oct 1; 29:A106.
  322. Arozullah AM, Henderson WG, Khuri S. Predictors of failure to rescue from postoperative pneumonia in patients undergoing major noncardiac surgery. Paper presented at: VA HSR&D National Meeting; 2001 Sep 1; Washington, DC.
  323. Arozullah AM, Henderson WG, Khuri S. Predictors of inpatient mortality among HIV patients with community-acquired pneumonia. Paper presented at: VA HSR&D National Meeting; 2001 Sep 1; Washington, DC.
  324. Halm EA, Switzer GE, Mittman BS, Walsh MB, Chang CC, Fine MJ. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? Journal of general internal medicine. 2001 Sep 1; 16(9):599-605.
  325. Levin KP, Hanusa BH, Rotondi A, Singer DE, Coley CM, Marrie TJ, Kapoor WN, Fine MJ. Arterial blood gas and pulse oximetry in initial management of patients with community-acquired pneumonia. Journal of general internal medicine. 2001 Sep 1; 16(9):590-8.
  326. Yealy DM, Fine MJ. Community-acquired pneumonia: epidemiology, risk stratification and the decision to admit. In: Rose BD, editor. UpToDate. Wellesley; 2001.
  327. Baine WB, Yu W, Summe JP. Epidemiologic trends in the hospitalization of elderly Medicare patients for pneumonia, 1991-1998. American journal of public health. 2001 Jul 1; 91(7):1121-3.
  328. Collard HR, Saint S. Prevention of ventilator-associated pneumonia. San Francisco, CA: University of California at San Francisco -Stanford University Evidence-based Practice Center; 2001 Jul 1. 185-198 p. Report No.: 01-E058.
  329. Arozullah AM, Henderson W, Khuri S. Predictors of Failure to Rescue from Postoperative Pneumonia in Patients Undergoing Major Noncardiac Surgery. Paper presented at: Society of General Internal Medicine Annual Meeting; 2001 May 1; San Diego, CA.
  330. Arozullah AM, Yarnold PR, Deloriaknoll M. Predictors of Inpatient Mortality Among HIV Patients with Community-Acquired Pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2001 May 1; San Diego, CA.
  331. Mortensen EM, Kapoor WN, Chang J, Fine MJ. Predictors of long-term mortality for patients with community-acquired pneumonia. Presented at: Society of General Internal Medicine Annual Meeting; 2001 Apr 1; San Diego, CA.
  332. Mortensen EM, Obrosky DS, Coley C, =et al. Predictors of pneumonia-related and non-pneumonia-related mortality in community-acquired pneumonia. Paper presented at: Society of General Internal Medicine Annual Meeting; 2001 Apr 1; San Diego, CA.
  333. Natarajan S, Rakes K. Diagnosis and Management of Pneumonia. In: Mainous AG, Pomeroy C, editors. Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic rRsistance. Totowa, NJ: Humana Press; 2001. 143-156 p.
  334. Chenoweth CE, Saint S, Martinez F, Lynch JP, Fendrick AM. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. Mayo Clinic proceedings. Mayo Clinic. 2000 Nov 1; 75(11):1161-8.
  335. Arozullah AM, Yarnold PR, Weinstein RA, Nwadiaro N, McIlraith TB, Chmiel JS, Sipler AM, Chan C, Goetz MB, Schwartz DN, Bennett CL. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. American journal of respiratory and critical care medicine. 2000 Apr 1; 161(4 Pt 1):1081-6.
  336. Halm EA, Switzer GE, Goldman J, Chang CH, Mittman BS, Walsh MB, Fine MJ. Determinants of Physician Familiarity with and Use of National and Local Pneumonia Practice Guidelines. Paper presented at: Association for Health Services Research Annual Meeting; 1999 Jun 1; Chicago, IL.
  337. Wipf JE, Lipsky BA, Hirschmann JV, Boyko EJ, Takasugi J, Peugeot RL, Davis CL. Diagnosing pneumonia by physical examination: relevant or relic? Archives of internal medicine. 1999 May 24; 159(10):1082-7.
  338. Halm EA, Mittman BS, Walsh MB, Switzer GE, Chang CH, Fine MJ. The Antibiotic conversion decision in patients hospitalized with pneumonia: Do generalists and specialists think alike? Paper presented at: Society of General Internal Medicine Annual Meeting; 1999 Apr 1; San Francisco, CA.
  339. Switzer GE, Halm EA, Goldman J, Chang CH, Mittman BS, Walsh MB, Fine MJ. Physician familiarity with and use of national and local pneumonia practice guidelines. Paper presented at: Society of General Internal Medicine Annual Meeting; 1999 Apr 1; San Francisco, CA.
  340. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum. 1999 Apr 1; 42(4):780-9.
  341. Bennett CL, Ilraith T. Corticosteroid Utilization and Outcomes in HIV Associated Pneumocystis Carinii Pneumonia: Three-fold Higher Mortality Among Severely Ill Patients when Corticosteroids given by CEC Guidelines. Paper presented at: VA HSR&D National Meeting; 1999 Feb 25; Washington, DC.

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.